Very close to these discrepancies, ET-1 has been shown to be involved in the cardiac hypertrophy induced by angiotensin-II [83] or sympathomimetics such as norepinephrine mainly through ETA receptor [84]. Here, EDN1 is linked to cardiac hypertrophy.